Skin Antiseptic Products Market by Form (Lotions, Ointment, Powder), Type (Alcohol-based Solutions, Benzalkonium Chloride-based Solutions, Chlorhexidine-based Solutions), Application, Distribution - Global Forecast 2024-2030
Description
Skin Antiseptic Products Market by Form (Lotions, Ointment, Powder), Type (Alcohol-based Solutions, Benzalkonium Chloride-based Solutions, Chlorhexidine-based Solutions), Application, Distribution - Global Forecast 2024-2030
The Skin Antiseptic Products Market size was estimated at USD 8.54 billion in 2023 and expected to reach USD 9.33 billion in 2024, at a CAGR 9.60% to reach USD 16.24 billion by 2030.
Skin antiseptics are the chemical substances applied to the skin to inhibit microbial growth and reduce the risk of surgical site infections (SSIs) occurring within 30 days of the procedure. Antiseptic agents used in dermatological surgery generally include chloroxylenol, chlorhexidine, isopropyl alcohol, povidone-iodine, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. Skin antiseptic acts by targeting the disruption of cell walls and cellular enzyme inactivation. Increased prevalence of hospital-acquired infections and rising cases of sports injuries and road accidents propelled the market growth. In addition, a surge in the utilization of surgical units & endoscopic procedures and an increase in the adoption of personal hygiene created the need for skin antiseptics. Moreover, contamination of skin antiseptics during the manufacturing process can lead to harmful effects, including skin irritation, rashes, and redness may limit the adoption of skin antiseptics. Furthermore, favorable government initiatives for developing healthcare infrastructure and developing novel skin antiseptics products by the companies are expected to increase the market growth.
Regional Insights
The skin antiseptic products market in the Americas is rapidly developing owing to the growing need for wound care and management and advancement in skin antiseptic products manufacturing and compositions. The ongoing efforts by the native market players for novel product development and launch have improved the availability of skin antiseptic products in the Americas. The growing burden of road accidents and injuries has propelled the usage of skin antiseptic products in the Asia-Pacific region. As per the World Health Organization (WHO), more than 1 million people in India suffer mild to severe burns yearly. Furthermore, the rise in the prevalence of hospital-acquired infections and supportive government norms for skin antiseptics products has increased the customer preference for wound care and management products in the EMEA region. The elevated concerns associated with road accidents in developed Middle East economies are expected to bolster the need for the market of skin antiseptic products in the coming years.
Market Insights
- Market Dynamics
The market dynamics represent an ever-changing landscape of the Skin Antiseptic Products Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.- Market Drivers
- Rising cases of sports injuries and road accidents
- Surge in the utilization of skin antiseptic in dermatological procedures
- Market Restraints
- Overuse or misuse of skin antiseptic products and its related product recalls
- Market Opportunities
- Favorable governmental initiatives for healthcare infrastructure development
- Development of novel and organic skin antiseptic products
- Market Challenges
- Compatibility issues of skin antiseptic products with other medical products
- Market Segmentation Analysis
- Form: Increasing utilizations of lotions for their moisturizing capabilities, making them suitable for dry skin conditions.
- Distribution: Growing preference for online distribution channel by consumer due to ease of purchase
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Skin Antiseptic Products Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Skin Antiseptic Products Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments- WellSpring Consumer Healthcare Acquires Iconic OTC Skin Care Brands from Baye
Wellspring Consumer Healthcare has recently acquired several over-the-counter skincare brands from pharmaceutical giant Bayer. The acquisition includes well-known and established brands such as Coppertone, Dr. Scholl's, and Tinactin. This strategic move allows Wellspring to expand its product portfolio and increase its market share in the skin antiseptic products market. With the ongoing global pandemic increasing demand for products promoting hygiene and preventing infection spread, this acquisition is a timely and prudent investment for Wellspring. As a result of this acquisition, Wellspring is poised to emerge as a big competitor in the skin antiseptic products market.
3M Health Care introduces new 3M SoluPrep S Sterile Antiseptic Solution, an optimized skin prep product for presurgical applications
The new 3M Soluprep S Sterile Antiseptic Solution is a revolutionary skin antiseptic product optimized for presurgical applications. It features an advanced formula that rapidly kills microbial organisms and uses the active ingredient Chlorhexidine Gluconate to protect against bacteria, yeast, and fungi. This simple-to-use product is designed for single use, making it ideal for clinical settings where there is a need for easy application and disposal. A unique packaging system also helps preserve the contents of the solution, ensuring that it remains active throughout its shelf life. With this new product, 3M Health Care has further solidified its position as the top industry leader in providing comprehensive solutions for skin antiseptics.
Dettol enters a new category with Dettol multi-use antiseptic cream
Dettol, a brand of skin antiseptic products, launched a new product: Dettol Multi-Use Antiseptic Cream. This highly-anticipated product is formulated to provide superior protection against germs and promote healthy skin. The cream is enriched with moisturizing ingredients, which help replenish the natural oils in the skin and leave it feeling soft and nourished. It is used for various purposes, including protecting against cuts and grazes, protecting against any fungal or bacterial infection, relieving irritation from insect bites, refreshing the skin after exercise, and helping to heal minor scrapes and burns. Dettol's extensive range of products provides consumers an all-inclusive solution for their skincare needs.
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Skin Antiseptic Products Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Skin Antiseptic Products Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Aarsha Chemicals Pvt. Ltd., Acto Pharma, B. Braun Melsungen AG, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Cardinal Health, Inc., Cipla Ltd., Dynarex Corporation, Ecolab Inc., GlaxoSmithKline PLC, Henry Schein, Inc., Himalaya Wellness Company, Johnson & Johnson Services, Inc., Kimberly-Clark Corporation, Microgen Hygiene Pvt. Ltd., Microwin Labs Pvt. Ltd., Mölnlycke Health Care AB, Otsuka Holdings Co., Ltd., Perrigo Company PLC, Professional Disposables International, Inc., PSK Pharma Pvt. Ltd., Purdue Pharma L.P., Raman & Weil Pvt. Ltd., Reckitt Benckiser Group PLC, Safetec of America, Inc., Sanmed Healthcare Pvt. Ltd., Sanofi S.A., Schülke & Mayr GmbH, Smith & Nephew PLC, Stryker Corporation, Voda Chemicals Private Limited, and Xttrium Laboratories, Inc..
Market Segmentation & Coverage
This research report categorizes the Skin Antiseptic Products Market to forecast the revenues and analyze trends in each of the following sub-markets:- Form
- Lotions
- Ointment
- Powder
- Solutions
- Swab Sticks
- Wipes
- Type
- Alcohol-based Solutions
- Benzalkonium Chloride-based Solutions
- Chlorhexidine-based Solutions
- Hydrogen Peroxide
- Iodine-based Solutions
- Octenidine Dihydrochloride
- Application
- Skin Preparation for Injections
- Skin Preparation for Wounds
- Non-surgical
- Surgical
- Distribution
- Hospitals & Healthcare Facilities
- Online
- Pharmacies & Drugstores
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
- Americas
- Market Drivers
Table of Contents
193 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising cases of sports injuries and road accidents
- 5.1.1.2. Surge in the utilization of skin antiseptic in dermatological procedures
- 5.1.2. Restraints
- 5.1.2.1. Overuse or misuse of skin antiseptic products and its related product recalls
- 5.1.3. Opportunities
- 5.1.3.1. Favorable governmental initiatives for healthcare infrastructure development
- 5.1.3.2. Development of novel and organic skin antiseptic products
- 5.1.4. Challenges
- 5.1.4.1. Compatibility issues of skin antiseptic products with other medical products
- 5.2. Market Segmentation Analysis
- 5.2.1. Form: Increasing utilizations of lotions for their moisturizing capabilities, making them suitable for dry skin conditions.
- 5.2.2. Distribution: Growing preference for online distribution channel by consumer due to ease of purchase
- 5.3. Market Trend Analysis
- 5.3.1. Proliferation of skin antiseptic products with the presence of major players in the U.S.
- 5.3.2. Increasing need to manage rising prevalence of burn injuries, and chronic wounds in Asia-Pacific region
- 5.3.3. Growing burden of hospital-acquired infections increasing the need for skin antiseptic products in the EMEA region
- 5.4. Cumulative Impact of Russia-Ukraine Conflict
- 5.5. Cumulative Impact of High Inflation
- 5.6. Porter’s Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
- 5.7. Value Chain & Critical Path Analysis
- 5.8. Regulatory Framework Analysis
- 5.9. Client Customization
- 6. Skin Antiseptic Products Market, by Form
- 6.1. Introduction
- 6.2. Lotions
- 6.3. Ointment
- 6.4. Powder
- 6.5. Solutions
- 6.6. Swab Sticks
- 6.7. Wipes
- 7. Skin Antiseptic Products Market, by Type
- 7.1. Introduction
- 7.2. Alcohol-based Solutions
- 7.3. Benzalkonium Chloride-based Solutions
- 7.4. Chlorhexidine-based Solutions
- 7.5. Hydrogen Peroxide
- 7.6. Iodine-based Solutions
- 7.7. Octenidine Dihydrochloride
- 8. Skin Antiseptic Products Market, by Application
- 8.1. Introduction
- 8.2. Skin Preparation for Injections
- 8.3. Skin Preparation for Wounds
- 9. Skin Antiseptic Products Market, by Distribution
- 9.1. Introduction
- 9.2. Hospitals & Healthcare Facilities
- 9.3. Online
- 9.4. Pharmacies & Drugstores
- 10. Americas Skin Antiseptic Products Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Skin Antiseptic Products Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Skin Antiseptic Products Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.3.1. WellSpring Consumer Healthcare Acquires Iconic OTC Skin Care Brands from Baye
- 13.3.2. 3M Health Care introduces new 3M SoluPrep S Sterile Antiseptic Solution, an optimized skin prep product for presurgical applications
- 13.3.3. Dettol enters a new category with Dettol multi-use antiseptic cream
- 13.3.4. Schülke & Mayr GmbH acquires Spanish company Vesismin Health
- 13.3.5. Schülke continues its growth path and expands its presence in Southern Europe
- 13.3.6. Islacare wins Innovate UK grant to tackle surgical site infections
- 13.3.7. LANXESS completes acquisition of IFF’s microbial control business
- 13.3.8. New Cardinal Health surgical drape helps reduce surgical site contamination risk
- 13.3.9. PDI Announces Strategic Partnership with APIC
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.2. Key Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
